Morepen transfers subsidiary shares to key management
Morepen Laboratories Limited transferred 1,62,000 equity shares of subsidiary Morepen Medipath Limited to Mr. Anubhav Suri, Head - Medical Devices Business. This reduces the company's stake in MML to 51%, though it remains a subsidiary. Mr. Suri's shareholding increased from 0.10% to 9.10%.
*this image is generated using AI for illustrative purposes only.
morepen laboratories has transferred 1,62,000 equity shares of its subsidiary, Morepen Medipath Limited (MML), to Mr. Anubhav Suri, the Head of its Medical Devices Business. The decision follows 15 years of significant growth in the medical devices sector under his leadership. The company stated that the transfer is intended to align Mr. Suri's interests with the long-term growth and strategic objectives of MML, ensuring continuity of leadership as the business expands.
As a result of this transaction, Morepen Laboratories' shareholding in MML has decreased from 60% to 51%. Despite the reduction, MML will continue to remain a subsidiary of the company and will be consolidated in its financial statements. The consideration for the transfer was mutually agreed upon between the parties involved.
The shareholding pattern of MML has been revised following the transfer. Mr. Anubhav Suri, who previously held 0.10% equity shares, now holds 9.10% of the total paid-up share capital. The details of the pre and post-transaction shareholding are outlined below.
| Shareholder | Category | Pre-Transaction Shares | Pre-Transaction % | Post-Transaction Shares | Post-Transaction % |
|---|---|---|---|---|---|
| Morepen Laboratories Limited | Promoter | 10,80,000 | 60.00% | 9,18,000 | 51.00% |
| Entity/ Persons belonging to promoters & promoter group of MLL | Promoter Group | 6,08,200 | 33.79% | 6,08,200 | 33.79% |
| Mr. Anubhav Suri | Promoter Group | 1,800 | 0.10% | 1,63,800 | 9.10% |
| Others | Public | 1,10,000 | 6.11% | 1,10,000 | 6.11% |
| Total | 18,00,000 | 100% | 18,00,000 | 100% |
The disclosure was made in terms of Regulation 30 read with a SEBI master circular. The company's Corporate Office is located in Gurugram, Haryana, and its Registered Office is in Baddi, Himachal Pradesh.
Historical Stock Returns for Morepen Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.08% | -2.10% | +4.09% | -4.13% | -31.59% | -25.25% |
Could Morepen Laboratories further dilute its stake in MML below 51% in the future to bring in external investors or strategic partners for the medical devices business?
How might this equity transfer impact MML's valuation and its potential for an independent IPO given the leadership alignment strategy?
Will this ownership restructuring influence MML's ability to secure new contracts or partnerships in the rapidly growing Indian medical devices sector?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
